# GlaxoSmithKline Biologicals SA – FDA Inspection, Feb 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52
Source feed: FDA_Inspections

> FDA inspection 1304664 of GlaxoSmithKline Biologicals SA, February 27, 2026. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304664
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2026-02-27
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1215345 - 2023-06-23
- [FDA Inspection 1099397 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/beae85df-4d31-45f7-93a5-448b49902f50)
- [FDA Inspection 1007184 - 2017-01-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824)
- FDA Inspection 900625 - 2014-10-02
- FDA Inspection 818683 - 2012-10-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)
- [FDA Associated Person](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
